Meryx Overview

  • Founded
  • 2013
  • Status
  • Private
  • Employees
  • 3
  • Latest Deal Type
  • Seed
  • Latest Deal Amount
  • $2.5M
Latest Deal Amount
  • Investors
  • 2

Meryx General Information


Developer of a therapeutic drug designed to provide the treatment of cancer. The company's platform develops mer tyrosine kinase inhibitor for multiple indications, including cancer and viral infection, enabling patients to outlive cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 510 Meadowmont Village Circle
  • Suite 359
  • Chapel Hill, NC 27517
  • United States
+1 (919) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Meryx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 29-Jun-2015 $2.5M 00.000 Completed Generating Revenue
1. Early Stage VC (Series A) 29-Dec-2014 00.000 00.000 000.00 Completed Generating Revenue
To view Meryx’s complete valuation and funding history, request access »

Meryx Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
To view Meryx’s complete cap table history, request access »

Meryx Executive Team (4)

Name Title Board Seat Contact Info
Stephen Frye Ph.D Co-Founder, Chief Executive Officer, Co-Chairman and Board Member
H. Earp Board Member & Co-Founder
Douglas Graham Ph.D Co-Founder & Board Member
Seth Rudnick MD Co-Chairman
To view Meryx’s complete executive team members history, request access »

Meryx Board Members (7)

Name Representing Role Since
Douglas Graham Ph.D Meryx Co-Founder & Board Member 000 0000
Fred Eshelman Eshelman Ventures Board Member 000 0000
H. Earp Meryx Board Member & Co-Founder 000 0000
Rajesh Malik MD Self Board Member 000 0000
Sailash Patel Meryx Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Meryx Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Meryx Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Seth Rudnick Angel (individual) Minority 000 0000 000000 0
Eshelman Ventures Venture Capital Minority 000 0000 000000 0
To view Meryx’s complete investors history, request access »